SEI Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

SEI Investments’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.3K	Sell	22,016 -6,077	-22%	-$20.2K	﹤0.01%	3211
2026 Q1	$101K	Buy	+28,093	New	+$112K	﹤0.01%	3096
2024 Q4	–	Sell	-17,060	Closed	-$315K	–	2780
2024 Q3	$315K	Buy	+17,060	New	+$349K	﹤0.01%	2337
2024 Q1	–	Sell	-7,268	Closed	-$218K	–	2688
2023 Q4	$218K	Sell	7,268 -2,530	-26%	-$55.8K	﹤0.01%	2416
2023 Q3	$201K	Buy	+9,798	New	+$178K	﹤0.01%	2431
2021 Q2	–	Sell	-12,997	Closed	-$713K	–	2618
2021 Q1	$713K	Hold	12,997	–	–	﹤0.01%	1883
2020 Q4	$713K	Buy	+12,997	New	+$474K	﹤0.01%	1827

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SEI Investments's RCKT Position: Q2 2026 in Review

SEI Investments reduced its Rocket Pharmaceuticals (RCKT) stake by 22% in Q2 2026, selling an estimated $20.2K and leaving 22,016 shares worth $75.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

SEI Investments first reported a position in RCKT in Q4 2020 and has held it in 7 quarters since. The position peaked at $713K in Q1 2021. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

SEI Investments held 22,016 shares of Rocket Pharmaceuticals worth $75.3K as of Q2 2026.
SEI Investments sold 6,077 Rocket Pharmaceuticals shares in Q2 2026, an estimated $20.2K.
Rocket Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3211 holding.
SEI Investments first reported a position in Rocket Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
SEI Investments's Rocket Pharmaceuticals position peaked at $713K in Q1 2021.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.